A13Aflibercept efficacy according to sidedness, RAS and...

Annals of Oncology 2017 / 10 Vol. 28; Iss. suppl_6

A13Aflibercept efficacy according to sidedness, RAS and BRAF mutations. Findings from the VELOUR trial in second line therapy of advanced colorectal cancer patients

Maiello, E, Pomella, V, Wirapati, P, Di Bartolomeo, M, Zampino, M G, Leone, F, Latiano, T P, Pietrantonio, F, Ravenda, P S, Marino, D, Tejpar, S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx422.012
Date:
October, 2017
File:
PDF, 55 KB
english, 2017
Conversion to is in progress
Conversion to is failed